Cooper JD - Search Results

1

Intrathecal enzyme replacement therapy improves motor function and survival in a preclinical mouse model of infantile neuronal ceroid lipofuscinosis.

Lu JY, Nelvagal HR, Wang L, Birnbaum SG, Cooper JD, Hofmann SL. Lu JY, et al. Among authors: cooper jd. Mol Genet Metab. 2015 Sep-Oct;116(1-2):98-105. doi: 10.1016/j.ymgme.2015.05.005. Epub 2015 May 12. Mol Genet Metab. 2015. PMID: 25982063

2

Progress towards understanding the neurobiology of Batten disease or neuronal ceroid lipofuscinosis.

Cooper JD. Cooper JD. Curr Opin Neurol. 2003 Apr;16(2):121-8. doi: 10.1097/01.wco.0000063762.15877.9b. Curr Opin Neurol. 2003. PMID: 12644737 Review.

3

Regional and cellular neuropathology in the palmitoyl protein thioesterase-1 null mutant mouse model of infantile neuronal ceroid lipofuscinosis.

Bible E, Gupta P, Hofmann SL, Cooper JD. Bible E, et al. Among authors: cooper jd. Neurobiol Dis. 2004 Jul;16(2):346-59. doi: 10.1016/j.nbd.2004.02.010. Neurobiol Dis. 2004. PMID: 15193291

4

Adeno-associated virus 2-mediated gene therapy decreases autofluorescent storage material and increases brain mass in a murine model of infantile neuronal ceroid lipofuscinosis.

Griffey M, Bible E, Vogler C, Levy B, Gupta P, Cooper J, Sands MS. Griffey M, et al. Neurobiol Dis. 2004 Jul;16(2):360-9. doi: 10.1016/j.nbd.2004.03.005. Neurobiol Dis. 2004. PMID: 15193292

5

Late onset neurodegeneration in the Cln3-/- mouse model of juvenile neuronal ceroid lipofuscinosis is preceded by low level glial activation.

Pontikis CC, Cella CV, Parihar N, Lim MJ, Chakrabarti S, Mitchison HM, Mobley WC, Rezaie P, Pearce DA, Cooper JD. Pontikis CC, et al. Among authors: cooper jd. Brain Res. 2004 Oct 15;1023(2):231-42. doi: 10.1016/j.brainres.2004.07.030. Brain Res. 2004. PMID: 15374749

6

CNS-directed AAV2-mediated gene therapy ameliorates functional deficits in a murine model of infantile neuronal ceroid lipofuscinosis.

Griffey MA, Wozniak D, Wong M, Bible E, Johnson K, Rothman SM, Wentz AE, Cooper JD, Sands MS. Griffey MA, et al. Among authors: cooper jd. Mol Ther. 2006 Mar;13(3):538-47. doi: 10.1016/j.ymthe.2005.11.008. Epub 2005 Dec 20. Mol Ther. 2006. PMID: 16364693 Free article.

7

Distinct patterns of serum immunoreactivity as evidence for multiple brain-directed autoantibodies in juvenile neuronal ceroid lipofuscinosis.

Lim MJ, Beake J, Bible E, Curran TM, Ramirez-Montealegre D, Pearce DA, Cooper JD. Lim MJ, et al. Among authors: cooper jd. Neuropathol Appl Neurobiol. 2006 Oct;32(5):469-82. doi: 10.1111/j.1365-2990.2006.00738.x. Neuropathol Appl Neurobiol. 2006. PMID: 16972881

8

Progress towards understanding disease mechanisms in small vertebrate models of neuronal ceroid lipofuscinosis.

Cooper JD, Russell C, Mitchison HM. Cooper JD, et al. Biochim Biophys Acta. 2006 Oct;1762(10):873-89. doi: 10.1016/j.bbadis.2006.08.002. Epub 2006 Aug 10. Biochim Biophys Acta. 2006. PMID: 17023146 Free article. Review.

9

Successive neuron loss in the thalamus and cortex in a mouse model of infantile neuronal ceroid lipofuscinosis.

Kielar C, Maddox L, Bible E, Pontikis CC, Macauley SL, Griffey MA, Wong M, Sands MS, Cooper JD. Kielar C, et al. Among authors: cooper jd. Neurobiol Dis. 2007 Jan;25(1):150-62. doi: 10.1016/j.nbd.2006.09.001. Epub 2006 Oct 12. Neurobiol Dis. 2007. PMID: 17046272 Free PMC article.

10

Moving towards therapies for juvenile Batten disease?

Cooper JD. Cooper JD. Exp Neurol. 2008 Jun;211(2):329-31. doi: 10.1016/j.expneurol.2008.02.016. Epub 2008 Mar 4. Exp Neurol. 2008. PMID: 18400221 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

840 results

Search Page

Filters